CURE Pharmaceutical Holding Corp. filed its 10-K on Apr 01, 2022 for the period ending Dec 31, 2021. In this report its auditor, Russell Bedford Stefanou Mirchandani LLP - RBSM LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.045 USD | -10.00% | +5.88% | -39.52% |
1st Jan change | Capi. | |
---|---|---|
-39.52% | 3.29M | |
+8.05% | 3,020B | |
+5.58% | 82.93B | |
+3.69% | 76.85B | |
-14.62% | 53.04B | |
+31.16% | 50.15B | |
-24.56% | 46.71B | |
+17.75% | 41.41B | |
+55.21% | 36.1B | |
-10.24% | 24.64B |
- Stock Market
- Equities
- AVRW Stock
- News Avenir Wellness Solutions, Inc.
- CURE Pharmaceutical Holding Corp. Auditor Raises 'Going Concern' Doubt